unisa logo

Australian Centre for Precision Health

Population health research to improve the future of health

random crowd of people walking in a town setting

Improving cancer screening and surveillance

With around one in two Australian men and one in three Australian women likely to be diagnosed at some point in their lives, cancer in its many forms is one of Australia’s major research and health care priorities. Despite the growing disease burden, prognoses for many cancer patients are improving, with survival rates on the rise and an increasingly effective variety of screening techniques, therapies and preventive strategies available.

Ensuring our health care systems make the best use of all such strategies is one of the key aims of the Cancer Epidemiology and Population Health Research Group (CEPH). Examining the continuum from prevention to screening, to treatment and patient outcomes, the group works to produce and translate research evidence to improve patient outcomes and inform decision makers on how best to deliver care to the many Australians requiring cancer-related health services each year.

CEPH is headed by Professor David Roder, a key advisor to government, health bodies and non-government organisations on cancer policy.

Areas of research interest include:

  • Primary research and scientific discovery
  • Evidence distillation for policy development
  • Health service evaluation and surveillance
  • Cancer control indicator development for service monitoring
  • Provision of technical support and leadership for health service development
  • Research infrastructure development
  • Policy development

The group currently works in collaboration or under contract with Cancer Australia, Cancer Institute New South Wales, Cancer Council South Australia, South Australian Health and Medical Research Institute (SAHMRI), CanTeen and National and State Health Government agencies across Australia.

Current research projects